Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon. It causes ulcers, or open sores, in the colon’s lining, leading to symptoms like diarrhea, bleeding,…
Join Elisa K. Boden, MD, Ryan Ungaro, MD, and patient advocate Nathan Marohn in this insightful social media event, “The Intersection of Histologic, Endoscopic, and Symptomatic Remission in…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome (ACS) or ST-elevation myocardial infarction (STEMI), the proton pump inhibitor (PPI) esomeprazole is superior to the H2-receptor…
NEW YORK (Reuters Health) – Inflammatory bowel disease (IBD) activity is an independent risk factor for the development of venous thromboembolic events (VTEs). That’s one of the findings…
NEW YORK (Reuters Health) – Complete visualization of the entire small intestine is achieved more easily with double-balloon endoscopy than with single-balloon endoscopy, according to a report from…
NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
NEW YORK (Reuters Health) – Patients with relapsing mild-to-moderate ulcerative colitis (UC) on immunosuppressive therapy may benefit from the addition of a high-potency probiotic mixture (VSL#3; VSL Pharmaceuticals…
NEW YORK (Reuters Health) – The “dramatic benefits” of probiotic supplements for reducing death and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) preterm neonates have been…
NEW YORK (Reuters Health) – In adults with moderate-to-severe active Crohn’s disease, treatment with infliximab plus azathioprine, or infliximab alone, led to significantly higher rates of corticosteroid-free clinical…
NEW YORK (Reuters Health) – Prophylactic antibiotics may improve survival of burn patients, a meta-analysis suggests, although the authors acknowledge that the quality of the supporting data is…
NEW YORK (Reuters Health) – Long-term treatment with clofazimine or nitroimidazoles may help control Crohn’s disease, according to the authors of a systematic review and meta-analysis. Several bacteria…
NEW YORK (Reuters Health) – Patients taking azathioprine or 6-mercaptopurine for inflammatory bowel disease (IBD) have more than a five-times higher risk of developing a lymphoproliferative disorder compared…
